Latest Breaking News On - Dipti amin - Page 1 : vimarsana.com

Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14A Information .

San diegoUnited statesSan franciscoCity ofUnited kingdomSan bernardinoUniversity of california irvineUniversity of southern californiaJohnson schoolPalo altoAlfredd kingsleyNealc bradsherDipti aminLos angelesAngusc russellDeborah andrews

Lineage Cell Therapeutics : Results of Annual Meeting was held on September 6, 2023 -Today at 03:01 am

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT .

United statesGeorgea samuelBrianm culleyAngusc russellDon baileyNealc bradsherDipti aminAnula jayasuriyaMichaelh mulroyDeborah andrewsAlfredd kingsleyLineage cell therapeutics incSecurities exchangeExchange commission onMeeting of lineage cell therapeutics incSecurities exchange act

Families continue to save and improve lives through organ donation - Buckinghamshire Healthcare NHS Trust

Families continue to save and improve lives through organ donation - Buckinghamshire Healthcare NHS Trust
buckshealthcare.nhs.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from buckshealthcare.nhs.uk Daily Mail and Mail on Sunday newspapers.

United kingdomDipti aminAnthony clarksonTissue donation committeeBuckinghamshire healthcareOrgan donationTransplantation activityNon executive directorTissue donationDonor register

Lineage Cell Therapeutics, Inc Forecasted to Earn FY2023 Earnings of ($0 29) Per Share (NYSEAMERICAN:LCTX)

Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Get Rating) – Research analysts at Cantor Fitzgerald issued their FY2023 earnings per share estimates for Lineage Cell Therapeutics in a report issued on Monday, June 6th. Cantor Fitzgerald analyst K. Kluska anticipates that the company will post earnings per share of ($0.29) for the year. Lineage Cell Therapeutics […]

United statesDipti aminDawson jamesGoldman sachs group incMirabella financial servicesZacks investment researchMaxim groupCharles schwab investment management incLineage cell therapeutics incCantor fitzgeraldWealth architectsLineage cell therapeuticsGet ratingCell therapeuticsInvestment researchDirector dipti amin

Brokerages Set Lineage Cell Therapeutics, Inc (NYSEAMERICAN:LCTX) Price Target at $6 50

Shares of Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Get Rating) have been assigned an average rating of “Buy” from the six analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month […]

United statesDipti aminDawson jamesMaxim groupLineage cell therapeutics incZacks investment researchMillennium managementFund management coRoyal bankLineage cell therapeuticsGet ratingMarketbeat ratingsInvestment researchCell therapeuticsDirector dipti aminFund management